Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration

PURPOSE: Intravitreal injection of anti-VEGF drugs has become standard therapy for patients with exudative age-related macular degeneration (AMD). However, some patients do not exhibit sufficient response to the drugs for suppression of choroidal neovascularization activity. We investigated the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Naoko, Otsuji, Tsuyoshi, Tsumura, Akiko, Miki, Katsuaki, Sakai, Yukio, Nishimura, Tetsuya, Takahashi, Kanji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643053/
https://www.ncbi.nlm.nih.gov/pubmed/31409963
http://dx.doi.org/10.2147/OPTH.S206910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643053/
https://www.ncbi.nlm.nih.gov/pubmed/31409963
http://dx.doi.org/10.2147/OPTH.S206910

Ejemplares similares